Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor.

Autor: Vythoulkas D; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Lazana I; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Kroupis C; Clinical Biochemistry and Molecular Diagnostics, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Gavriilaki E; Hematology and Bone Marrow Transplantation Department, 'G. Papanikolaou' General Hospital, 57010 Thessaloniki, Greece., Konstantellos I; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Bousiou Z; Hematology and Bone Marrow Transplantation Department, 'G. Papanikolaou' General Hospital, 57010 Thessaloniki, Greece., Chondropoulos S; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Griniezaki M; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Vardi A; Hematology and Bone Marrow Transplantation Department, 'G. Papanikolaou' General Hospital, 57010 Thessaloniki, Greece., Gkirkas K; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Karagiannidou A; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Batsis I; Hematology and Bone Marrow Transplantation Department, 'G. Papanikolaou' General Hospital, 57010 Thessaloniki, Greece., Stamouli M; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece., Sakellari I; Hematology and Bone Marrow Transplantation Department, 'G. Papanikolaou' General Hospital, 57010 Thessaloniki, Greece., Tsirigotis P; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, 'ATTIKON' University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Apr 09; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 09.

Repetitively administered low-dose donor lymphocyte infusion for prevention of relapse after allogeneic stem cell transplantation in patients with high-risk acute leukemia

Autor: Tsirigotis, P. Gkirkas, K. Kitsiou, V. Chondropoulos, S. Athanassiades, T. Thomopoulos, T. Tsirogianni, A. Stamouli, M. Karagiannidi, A. Siafakas, N. Pappa, V. Nagler, A.

Background: Patients with high-risk acute leukemia have a high risk of relapse after allo-geneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate, various therapeutic methods have been implemented into clinical practice.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::e90df33092fb6a04030f03231aa27c39
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3077100

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders.

Autor: Symeonidis A; University of Patras Medical School, Hematology Division, Patras, Greece., Chondropoulos S; University General Hospital Attikon, Athens, Greece., Verigou E; Hematology Division, General University Hospital of Patras, Rion of Patras, Greece., Lazaris V; Hematology Division, General University Hospital of Patras, Rion of Patras, Greece., Kourakli A; Hematology Division, General University Hospital of Patras, Rion of Patras, Greece., Tsirigotis P; Department of Medicine, School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece.

Publikováno v: Frontiers in oncology [Front Oncol] 2022 Aug 05; Vol. 12, pp. 884723. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).

Balanced control of both hyper and hypo-inflammatory phases as a new treatment paradigm in sepsis

Autor: Tsirigotis, P. Chondropoulos, S. Gkirkas, K. Meletiadis, J. Dimopoulou, I.

The immune response of the host against invading pathogens is clinically manifested as sepsis. Sepsis is a complicated process characterized by distinct phases that usually occur in a sequential manner. The initial hyper-inflammation helps in elimina

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0f65a1a5ade3651a00f3ed7690de1d8a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3101162

Allogeneic Stem Cell Transplantation with a Novel Reduced Intensity Conditioning Regimen for the Treatment of Patients with Primary Cutaneous T-cell Lymphomas.

Autor: Stamouli M; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Gkirkas K; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Karagiannidi A; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Iliakis T; Hematology Division, 1st Department of Internal Medicine, Propaedeutic, LAIKON General Hospital, National and Kapodistrian University of Athens, Greece., Chondropoulos S; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Thomopoulos T; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Nikolaou V; 1st Department of Dermatology, Syggros Hospital, National and Kapodistrian University of Athens, Greece., Pappa V; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Papadavid E; 2nd Department of Dermatology, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece., Tsirigotis P; Hematology Division, 2nd Department of Internal Medicine, Propaedeutic, ATTIKON General University Hospital, National and Kapodistrian University of Athens, Greece.

Publikováno v: Clinical hematology international [Clin Hematol Int] 2021 Jun 12; Vol. 3 (2), pp. 72-76. Date of Electronic Publication: 2021 Jun 12 (Print Publication: 2021).